Youcare Pharmaceutical (SH:688658) Xin Lang Cai Jing·2025-08-27 03:15Company Overview - Yuyuan Pharmaceutical Group Co., Ltd. is located in Beijing Economic and Technological Development Zone and was established on August 14, 2001. The company went public on December 24, 2020. [1] - The main business of Yuyuan Pharmaceutical focuses on the research and production of high-end chemical drugs, with significant revenue contributions from cardiovascular drugs, digestive system drugs, diabetes medications, and anti-infection drugs. [1] Financial Performance - As of August 27, Yuyuan Pharmaceutical's stock price dropped by 5.09% to 30.18 CNY per share, with a trading volume of 118 million CNY and a turnover rate of 0.85%, resulting in a total market capitalization of 13.581 billion CNY. [1] - The revenue composition of the main business includes: cardiovascular drugs 55.67%, anti-infection drugs 20.88%, raw materials 8.73%, digestive system drugs 6.87%, diabetes drugs 4.85%, others 2.62%, and technical services 0.02%. [1] Fund Holdings - According to data, one fund under Dongfang Fund holds a significant position in Yuyuan Pharmaceutical. The Dongfang Innovation Medical Stock A (018045) held 76,400 shares in the second quarter, accounting for 6.07% of the fund's net value, making it the largest holding. [2] - The fund has experienced a floating loss of approximately 123,800 CNY as of the latest report. [2] Fund Manager Profile - The fund manager of Dongfang Innovation Medical Stock A is Xu Wenbo, who has a cumulative tenure of 10 years and 19 days. The total asset size of the fund is 1.112 billion CNY, with the best return during his tenure being 57.63% and the worst being -8.08%. [3]